Nordic Bioscience A/S
Nordic Bioscience A/S, headquartered in Denmark (DK), is a pioneering biotechnology company specialising in the development of innovative solutions for the healthcare industry. Founded in 2002, the company has established itself as a leader in biomarker research and diagnostics, focusing on areas such as fibrosis, osteoarthritis, and cardiovascular diseases. With a commitment to advancing personalised medicine, Nordic Bioscience offers unique products and services, including proprietary biomarker assays and clinical trial support. Their cutting-edge technologies are designed to enhance patient outcomes and streamline drug development processes. Recognised for its scientific excellence, Nordic Bioscience has achieved significant milestones, positioning itself as a trusted partner in the global biopharmaceutical landscape.
DitchCarbon Score
How does Nordic Bioscience A/S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nordic Bioscience A/S's score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nordic Bioscience A/S's reported carbon emissions
Nordic Bioscience A/S, headquartered in Denmark (DK), currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established specific reduction targets or commitments under initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. As a result, Nordic Bioscience A/S's climate commitments and strategies remain unspecified, indicating a potential area for development in their sustainability efforts. The absence of emissions data and reduction initiatives suggests that the company may be in the early stages of addressing its carbon footprint and climate impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nordic Bioscience A/S is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
